2m 2m 2m 2m 2m 2m 2m
AMNEAL PHRMCTL-A (AMRX)
NASDAQ
$18.75+$0.43 (+2.32%)
Price as of Aug 03, 2026 11:32 AM EDT- $5.9BMarket Cap
- 133.97%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
AMNEAL PHRMCTL-A (AMRX)
$18.75+$0.43 (+2.32%)
AMRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $18.32 | ||
Change | -$0.18 (-0.97%) | ||
Open | $18.17 | ||
High | $18.43 | ||
Low | $17.92 | ||
Previous Close | $18.50 | ||
Volume | 2,011,738 | ||
30-Day Average Volume | 1,838,233 | ||
1-Week Change | 2.23% | ||
1-Month Change | 5.83% | ||
1-Year Change | 133.97% | ||
3-Year Change | 472.50% | ||
5-Year Change | 271.60% | ||
Fundamentals | |||
Shares Outstanding | 319.3M | ||
Total Assets | $3.5B | ||
Market Cap | $5.9B | ||
Enterprise Value | $8.2B | ||
Period: QTR TTM FY | |||
Revenue | $722.5M | ||
Net Income | $62.3M | ||
Free Cash Flow | -$34.9M | ||
EBIT | $117.8M | ||
EBITDA | $147.8M | ||
Net Working Capital | $1.1B | ||
EPS | $0.19 | ||
Enterprise Value/EBITDA | 56 | ||
Enterprise Value/Revenue | 11 | ||
P/B | -129 | ||
P/E | 96 | ||
PEG | 1 | ||
Price/Free Cash Flow | -168 | ||
Price/Operating Cash Flow | -219 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 08/26/2013 | ||
Earnings & Revenue